Mesenchymal stem cells beyond regenerative medicine R Shammaa, AEH El-Kadiry, J Abusarah, M Rafei Frontiers in cell and developmental biology 8, 72, 2020 | 75 | 2020 |
Elucidating the Role of Protandim and 6‐Gingerol in Protection Against Osteoarthritis J Abusarah, H Benabdoune, Q Shi, B Lussier, J Martel‐Pelletier, M Malo, ... Journal of cellular biochemistry 118 (5), 1003-1013, 2017 | 64 | 2017 |
An overview of the role of lipid peroxidation-derived 4-hydroxynonenal in osteoarthritis J Abusarah, M Bentz, H Benabdoune, PE Rondon, Q Shi, JC Fernandes, ... Inflammation Research 66, 637-651, 2017 | 46 | 2017 |
Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis Q Shi, J Abusarah, G Baroudi, JC Fernandes, H Fahmi, M Benderdour Arthritis research & therapy 14, 1-14, 2012 | 42 | 2012 |
New evidence implicating 4‐hydroxynonenal in the pathogenesis of osteoarthritis in vivo Q Shi, J Abusarah, C Zaouter, F Moldovan, JC Fernandes, H Fahmi, ... Arthritis & Rheumatology 66 (9), 2461-2471, 2014 | 32 | 2014 |
Covalent binding of 4-hydroxynonenal to matrix metalloproteinase 13 studied by liquid chromatography–mass spectrometry M Golizeh, J Abusarah, M Benderdour, L Sleno Chemical research in toxicology 27 (9), 1556-1565, 2014 | 22 | 2014 |
Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice J Abusarah, F Khodayarian, N El-Hachem, N Salame, M Olivier, M Balood, ... Cell Reports Medicine 2 (12), 2021 | 20 | 2021 |
Thymoproteasome-Expressing Mesenchymal Stromal Cells Confer Protective Anti-Tumor Immunity via Cross-Priming of Endogenous Dendritic Cells JP Bikorimana, N El-Hachem, AEH El-Kadiry, J Abusarah, N Salame, ... Frontiers in immunology 11, 596303, 2021 | 15 | 2021 |
Promoting antigen escape from dendritic cell endosomes potentiates anti-tumoral immunity JP Bikorimana, N Salame, S Beaudoin, M Balood, T Crosson, J Abusarah, ... Cell Reports Medicine 3 (3), 2022 | 14 | 2022 |
CD146 defines a mesenchymal stromal cell subpopulation with enhanced suppressive properties JP Bikorimana, W Saad, J Abusarah, M Lahrichi, S Talbot, R Shammaa, ... Cells 11 (15), 2263, 2022 | 7 | 2022 |
Humoral immunity to allogeneic immunoproteasome-expressing mesenchymal stromal cells requires efferocytosis by endogenous phagocytes JP Bikorimana, J Abusarah, N Salame, N El-Hachem, R Shammaa, ... Cells 11 (4), 596, 2022 | 7 | 2022 |
Thymic rejuvenation: are we there yet J Abusarah, F Khodayarian, Y Cui, AEH El-Kadiry, M Rafei Gerontology, 41-62, 2018 | 7 | 2018 |
A novel sulfonyl-based small molecule exhibiting anti-cancer properties AEH El-Kadiry, J Abusarah, YE Cui, N El-Hachem, I Hammond-Martel, ... Frontiers in Pharmacology 11, 237, 2020 | 6 | 2020 |
TACIMA-218: a novel pro-oxidant agent exhibiting selective antitumoral activity J Abusarah, Y Cui, N El-Hachem, AEH El-Kadiry, I Hammond-Martel, ... Molecular Cancer Therapeutics 20 (1), 37-49, 2021 | 4 | 2021 |
An engineered Accum‐E7 protein‐based vaccine with dual anti‐cervical cancer activity JP Bikorimana, J Abusarah, M Gonçalves, R Farah, W Saad, S Talbot, ... Cancer Science 115 (4), 1102-1113, 2024 | 1 | 2024 |
Intratumoral administration of unconjugated Accum™ impairs the growth of pre‐established solid lymphoma tumors JP Bikorimana, N El‐Hachem, M Moreau, C Lawson, LH Tai, ... Cancer Science 114 (12), 4499-4510, 2023 | 1 | 2023 |
The CIt protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cells JP Bikorimana, N El-Hachem, J Abusarah, N Eliopoulos, S Talbot, ... Iscience 25 (12), 2022 | 1 | 2022 |
Engineering a novel cell-based vaccine using immunoproteasome-expressing mesenchymal stromal cells J Abusarah McGill University (Canada), 2020 | 1 | 2020 |
The role of transcription factor Nrf2 in osteoarthritis J Abusarah | 1 | 2015 |
Local delivery of accutox® synergises with immune-checkpoint inhibitors at disrupting tumor growth JP Bikorimana, N El-Hachem, J Abusarah, MP Gonçalves, R Farah, ... Journal of Translational Medicine 22 (1), 532, 2024 | | 2024 |